JSB Market Research: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. See More: http://goo.gl/tW6DQL
During the forecast period from 2012-2022, the growth of the ulcerative colitis market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
See More: http://goo.gl/tW6DQL
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Table 35: Product Efficacy Comparison - Humira vs. Remicade 123<br />
Table 36: Humira SWOT <strong>Analysis</strong>, 2014 125<br />
Table 37: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Humira, 2012-<strong>2022</strong> 126<br />
Table 38: Product Profile - Simponi 128<br />
Table 39: Simponi SWOT <strong>Analysis</strong>, 2014 130<br />
Table 40: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Simponi, 2012-<strong>2022</strong> 131<br />
Table 41: Product Profile - Apriso 133<br />
Table 42: Apriso SWOT <strong>Analysis</strong>, 2014 135<br />
Table 43: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Apriso, 2012-<strong>2022</strong> 136<br />
Table 44: Product Profile - Asacol HD 138<br />
Table 45: Asacol HD SWOT <strong>Analysis</strong>, 2014 141<br />
Table 46: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Asacol HD, 2012-<strong>2022</strong> 142<br />
Table 47: Product Profile - Lialda 143<br />
Table 48: Lialda SWOT <strong>Analysis</strong>, 2014 145<br />
Table 49: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Lialda, 2012-<strong>2022</strong> 146<br />
Table 50: Product Profile - Pentasa 147<br />
Table 51: Pentasa SWOT <strong>Analysis</strong>, 2014 149<br />
Table 52: <strong>Global</strong> Sales <strong>Forecast</strong>s ($m) for Pentasa, 2012-<strong>2022</strong> 150<br />
Table 53: Product Profile - Colazal 151<br />
Email ID- contact@jsbmarketresearch.com<br />
Tel No- 91 2241236650<br />
Published by- http:/www.jsbmarketresearch.com/
Change language